药物辅助电复律：抗心律失常药物的选择重要吗？ - Suppr

Suppr

超能文献

Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter?

作者信息

Dan Gheorghe-Andrei, Dobrev Dobromir

机构信息

"Carol Davila" University of Medicine and Farmacy, Bucharest, Romania.

"Colentina" University Hospital, Cardiology Department, Bucharest, Romania.

出版信息

Int J Cardiol Heart Vasc. 2019 Sep 1;24:100416. doi: 10.1016/j.ijcha.2019.100416. eCollection 2019 Sep.

DOI:10.1016/j.ijcha.2019.100416

PMID:31508481

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6727018/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f203/6727018/bee341ccee37/gr1.jpg

相似文献

Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter?药物辅助电复律：抗心律失常药物的选择重要吗？

Int J Cardiol Heart Vasc. 2019 Sep 1;24:100416. doi: 10.1016/j.ijcha.2019.100416. eCollection 2019 Sep.

Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?心房颤动：药物治疗对电复律有效性及并发症有何影响？

Can J Cardiol. 1998 Oct;14(10):1267-73.

Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.心脏复律后电重构的靶向药物逆转——氟卡尼短-长（Flec-SL）试验的原理与设计

Am Heart J. 2005 Nov;150(5):899. doi: 10.1016/j.ahj.2005.07.020.

Clinical effectiveness of antiarrhythmic treatment after electrical cardioversion in patients without structural heart disease.

Rev Esp Cardiol. 2008 Dec;61(12):1274-9. doi: 10.1016/s1885-5857(09)60055-4.

A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.一项针对计划进行直流电复律的房颤患者预防性使用抗心律失常药物（胺碘酮和索他洛尔）的随机试验。

Am Heart J. 2006 Apr;151(4):863.e1-6. doi: 10.1016/j.ahj.2005.09.009.

Long-term outcome of electrical cardioversion in patients with chronic atrial flutter.慢性心房扑动患者电复律的长期预后

Heart. 1997 Jan;77(1):56-61. doi: 10.1136/hrt.77.1.56.

Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation.

Int J Cardiol. 2003 Apr;88(2-3):157-66. doi: 10.1016/s0167-5273(02)00380-7.

Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity.静脉用维纳卡兰转复心房颤动的安全性和有效性：一种新的具有心房选择性的抗心律失常药物。

Expert Opin Drug Saf. 2012 Jul;11(4):671-9. doi: 10.1517/14740338.2012.679262. Epub 2012 May 26.

Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients.电复律后选择哪种抗心律失常药物：一项针对非瓣膜性心房颤动患者的研究。

PLoS One. 2018 May 22;13(5):e0197352. doi: 10.1371/journal.pone.0197352. eCollection 2018.

[Drug and electrical therapy of supraventricular tachyarrhythmias].[室上性快速心律失常的药物与电疗法]

Z Kardiol. 2000;89 Suppl 3:68-74.

引用本文的文献

Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction.《国际心脏病学杂志：心脏与血管》亮点：心力衰竭、心房颤动、冠状动脉疾病和心肌梗死。

Int J Cardiol Heart Vasc. 2019 Nov 20;25:100443. doi: 10.1016/j.ijcha.2019.100443. eCollection 2019 Dec.

本文引用的文献

Vernakalant and electrical cardioversion for AF - Safe and effective.维纳卡兰与房颤的电复律——安全且有效。

Int J Cardiol Heart Vasc. 2019 Jul 11;24:100398. doi: 10.1016/j.ijcha.2019.100398. eCollection 2019 Sep.

Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis.维纳卡兰转复近期发作心房颤动的疗效：系统评价和荟萃分析。

Europace. 2019 Aug 1;21(8):1159-1166. doi: 10.1093/europace/euz175.

Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis.胺碘酮在心房颤动择期电复律中的预治疗和后治疗：系统评价和荟萃分析。

Europace. 2019 Jun 1;21(6):856-863. doi: 10.1093/europace/euy310.

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol.评价一种新的心房颤动转复干预措施：渥太华心房颤动转复方案。

Europace. 2019 May 1;21(5):708-715. doi: 10.1093/europace/euy285.

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging.用于心房颤动的抗心律失常药物：即将出现新的进展。

Int J Cardiol Heart Vasc. 2018 Sep 13;21:11-15. doi: 10.1016/j.ijcha.2018.08.005. eCollection 2018 Dec.

Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios.口服抗凝药在具有复杂情况的心房颤动患者中用于预防卒中。

Int J Cardiol Heart Vasc. 2018 Aug 31;20:56-62. doi: 10.1016/j.ijcha.2018.08.003. eCollection 2018 Sep.

The long-term efficacy of concomitant maze IV surgery in patients with atrial fibrillation.迷宫IV手术联合治疗心房颤动患者的长期疗效。

Int J Cardiol Heart Vasc. 2018 Apr 13;19:20-26. doi: 10.1016/j.ijcha.2018.03.009. eCollection 2018 Jun.

Clinical and electrocardiographic characteristics for prediction of new-onset atrial fibrillation in asymptomatic patients with atrial premature complexes.无症状房性早搏患者新发房颤预测的临床及心电图特征

Int J Cardiol Heart Vasc. 2018 May 17;19:70-74. doi: 10.1016/j.ijcha.2018.05.002. eCollection 2018 Jun.

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).抗心律失常药物——临床应用与临床决策：欧洲心律协会（EHRA）和欧洲心脏病学会（ESC）心血管药理学工作组的共识文件，得到心律学会（HRS）、亚太心律学会（APHRS）和国际心血管药物治疗学会（ISCP）认可。

Europace. 2018 May 1;20(5):731-732an. doi: 10.1093/europace/eux373.

Does antiarrhythmic drugs premedication improve electrical cardioversion success in persistent atrial fibrillation?

J Electrocardiol. 2017 May-Jun;50(3):294-300. doi: 10.1016/j.jelectrocard.2016.12.004. Epub 2016 Dec 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验